PQ 699
699. Deputy Marc Ó Cathasaigh asked the Minister for Health if he plans to make the drug fenfluramine (Fintepla), used in the treatment of Dravet syndrome, available for reimbursement through the HSE in line with the recommendations made by the National Centre for Pharmacoeconomics; and if he will make a statement on the matter. [42603/24]
Introduced
22 October 2024
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
22 October 2024
Summary
699. Deputy Marc Ó Cathasaigh asked the Minister for Health if he plans to make the drug fenfluramine (Fintepla), used in the treatment of Dravet syndrome, available for reimbursement through the HSE in line with the recommendations made by the National Centre for Pharmacoeconomics; and if he will make a statement on the matter. [42603/24]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 22 October 2024
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2024-10-22/699/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2024-10-22/pq_699